The role of apoptosis in the pathogenesis, prognosis, and therapy of hematologic malignancies

Steven M. Kornblau

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Apoptosis or programmed cell death is a cellular process involved in the regulation of cell proliferation. Alterations in the expression of apoptosis-related proteins are a common observation in hematologic malignancies. Moreover, increased expression levels of certain apoptosis-related proteins have been correlated with poorer clinical outcomes. Recent advances in the studies of the molecular events associated with the regulation of apoptosis have greatly improved our understanding of the etiology of human leukemias and myelodysplasias. Furthermore, these studies have helped identify proteins and cellular processes that are unique to leukemic cells and that could serve as therapeutic targets, diagnostic markers, and useful indicators of prognosis. Measurements of the levels of expression of apoptotic proteins could be used to help customize the therapeutic modalities that are most effective for each patient.

Original languageEnglish
Pages (from-to)S41-S46
JournalLeukemia
Volume12
Issue numberSUPPL. 1
StatePublished - 1998
Externally publishedYes

Keywords

  • Apoptosis
  • Cytogenetics
  • bcl-2

Fingerprint

Dive into the research topics of 'The role of apoptosis in the pathogenesis, prognosis, and therapy of hematologic malignancies'. Together they form a unique fingerprint.

Cite this